Clinical Trial Update: Study Evaluating Combination of Levonorgestrel and Ethinyl Estradiol in Pre-Menstrual Dysphoric Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the combination of levonorgestrel and ethinyl estradiol for premenstrual dysphoric disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder

Drugs mentioned

• Levonorgestrel/ethinyl estradiol (Levonorgestrel/ethinyl estradiol)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Premenstrual Syndrome, Menstruation Disturbances | Phase 3 | Status: COMPLETED